Brief: Prospect Park Capital says will not receive milestone payment held onto upon sale of interest in IOI

Prospect Park Capital

29/03/2017 17:44

March 29 (Reuters) - Prospect Park Capital Corp  PPK.V  
    * Says advised by Serenity Pharmaceuticals co will not 
receive milestone payment which it held onto upon sale of 
interest in IOI 
    * Says prospect park's final return on its investment in IOI 
remains at 8%. 
    * Will not receive payment in light of Allergan exercising 
unilateral right to terminate license, transfer, development 
agreement with Serenity 
 
Source text for Eikon:  urn:newsml:reuters.com:*:nCCN1gnhGg 
Further company coverage:  PPK.V  
 
 ((Bangalore.newsroom@thomsonreuters.com;))